CME CME Group Inc.

$263.80▲ +3.07% Financials Other Last sync: just now Syncing
Key Metrics & Fundamentals
Market Cap
$95.32B
P/E Ratio
22.5
Div Yield
1.97%
52W Range
244.56 - 329.16
% vs 50 MA
-10.62%
% vs 200 MA
-9.23%
RSI-14
32.9
MACD Histogram
-2.6000
Beta (1Y vs SPY)
-0.26
Free Cash Flow
$1.24B
Gross Rev
$1.88B
Gross Profit
$1.66B
EBITDA
$248.50M
COGS
$223.00M
Operating Exp
$347.40M
Operating Income
$1.31B
EBIT
$1.31B
Pretax Income
$1.51B
Net Income
$1.15B
EPS (Diluted)
3.18
Price & Volume History
Volume (M)
Financial Overview - Income Statement Quarterly
AI Analysis
Generated May 27, 10:41 PM
Company Overview

CME Group operates leading global derivatives marketplaces, offering a broad range of futures and options products across asset classes including interest rates, equities, foreign exchange, energy, and agricultural commodities. It holds a dominant position as critical market infrastructure, benefiting from strong network effects and high barriers to entry in the exchange and clearing space.

Bull Case
  • CME Group maintains a near-monopoly in several key derivatives markets, acting as essential financial infrastructure with significant network effects and high barriers to entry.
  • Revenue is generated from diversified sources including transaction fees, market data services, and clearing, providing stability and resilience across various market conditions.
  • Increased market volatility often translates to higher trading volumes and greater demand for hedging instruments, directly boosting CME's transaction-based revenue.
  • The company typically generates robust free cash flow, supporting consistent dividend payments and share repurchases, enhancing shareholder value.
Bear Case
  • Periods of low market volatility can lead to reduced trading volumes and lower transaction fees, potentially impacting revenue growth.
  • As a critical financial infrastructure provider, CME Group is subject to significant regulatory oversight, with potential for new rules impacting operations or profitability.
  • While dominant, competition from other exchanges, OTC markets, and new fintech solutions in specific niches could pose a long-term threat.
  • Fluctuations in interest rates can affect the value of CME's cash holdings and the attractiveness of certain derivatives products, influencing trading activity.
Recent Performance

CME Group is currently trading at $279.10, down 15.2% from its 52-week high and experiencing a daily decline of 1.2%. The stock is trading below both its 50-day (-4.2%) and 200-day (-0.1%) moving averages, indicating a short-to-medium term downtrend or weakening momentum. The RSI-14 of 40.5 suggests the stock is not yet oversold but has room to decline further, reflecting recent selling pressure.

AI-generated analysis is for informational purposes only and does not constitute financial advice.

Not Financial Advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making any investment decisions. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙